ArticleJournal of clinical medicine2021
Comparison of Short- and Long-Term Prognosis between ST-Elevation and Non-ST-Elevation Myocardial Infarction.
Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Super Saturated Oxygen (SSO2) Therapy in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Action on Coronary Microcirculatory Dysfunction: Pilot Study
Occurrence of Severe Cardiac Rhythm and Conduction Disturbances in Emergency Department Patients With Non-ST Elevation Acute Coronary Syndrome
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.
- Restrictive versus Liberal Transfusion Strategies in Acute Myocardial Infarction and Anemia: A Meta-Analysis and Trial Sequential Analysis.Arquivos brasileiros de cardiologia · 2024Pooled it
- Real-world management and outcomes of myocardial infarction in a transitional country: insights from an 11-year observational study of 13,099 patients.BMC cardiovascular disorders · 2026Observational
- Supersaturated Oxygen Therapy for Coronary Microvascular Dysfunction in Patients With ST-Segment Elevation Myocardial Infarction: The IC-HOT-MICRO Pilot Study.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- The predictive value of platelet-to-high density lipoprotein cholesterol ratio and white blood cell-to-mean platelet volume ratio for coronary artery disease risk in STEMI patients.Frontiers in cardiovascular medicine · 2026Article
- Differences in treatment and outcome of patients with ST- elevation myocardial infarction (STEMI) and non-STEMI in Germany.PloS one · 2026Article
- The Correlation Between Triglyceride-Glucose Index (TyG Index) With the Severity of Acute New-Onset Heart Failure (NOHF) Complications in Acute Myocardial Infarction Based on Killip Classification.Cardiology research and practice · 2026Article
- Article
- Disparities by Race and Ethnicity in Percutaneous Coronary Intervention.JAMA network open · 2025Article
- Carotid Intima-Media Thickness Is Associated with Long-Term Mortality in Patients with Non-ST Segment Elevation Myocardial Infarction.Journal of clinical medicine · 2025Article
- Survivorship following myocardial infarction in a contemporary Australian cohort: defining cardiac versus non-cardiac mortality.Internal medicine journal · 2025Article
- Enhancing risk stratification post-myocardial infarction: prognostic value of NT-proBNP and fQRS.Biomarkers in medicine · 2025Article
- Physiology-Versus Angiography-Guided Complete Coronary Revascularization in STEMI Patients with Multivessel Disease: A Network Meta-Analysis.Journal of clinical medicine · 2025Review
- Long-term outcomes of cardiogenic shock and cardiac arrest complicating ST-elevation myocardial infarction according to timing of occurrence.European heart journal open · 2024Article
- Detection of Ventricular Tachycardia by an Implantable Cardiac Monitor 8 Months Post-myocardial Infarction.The Journal of innovations in cardiac rhythm management · 2024Article
- Injury minimization after myocardial infarction: focus on extracellular vesicles.European heart journal · 2024Review
- Cardiac cells and mesenchymal stem cells derived extracellular vesicles: a potential therapeutic strategy for myocardial infarction.Frontiers in cardiovascular medicine · 2024Review
- Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies-A Real-World Analysis.Cancers · 2023Article
- Relationship Between Body Mass Index and Outcomes in Acute Myocardial Infarction.Journal of clinical medicine research · 2022Article
- Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction.Cardiovascular diabetology · 2022Article
- Development and validation of a predictive model for adverse left ventricular remodeling in NSTEMI patients after primary percutaneous coronary intervention.BMC cardiovascular disorders · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAvailable data comparing long-term prognosis according to the type of acute coronary syndrome (ACS) are scarce, contradictory, and outdated. Our aim was to compare short- and long-term mortality in ST-elevated (STEMI) and non-ST-elevated myocardial infarction (non-STEMI) ACS patients.
methodsPatients presenting with an inaugural ACS during the year 2006 and living in one of the three areas in France covered by the Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) registry were included.
resultsA total of 1822 patients with a first ACS-1121 (61.5%) STEMI and 701 (38.5%) non-STEMI-were included in the study. At the 28-day follow-up, the mortality rates were 6.7% and 4.7% (
conclusionSTEMI patients have a worse vital prognosis than non-STEMI patients within 28 days following ACS. However, at the 10-year follow-up, STEMI and non-STEMI patients have a similar vital prognosis. From the 2nd year onwards following the occurrence of a first ACS, the patients become stable coronary artery disease patients with an annual mortality rate in the 2% range, regardless of the type of ACS they initially present with.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.